2021 Proteins C and S Testing Market: USA, Europe, Japan-Competitive Strategies, Country Forecasts, Innovative Technologies and Instrumentation
![](/report_cover/2215/2020-proteins-c-n-s-testing-market-usa-europe-japan-competitive-strategies-country-forecasts-innovative-technologies-n-instrumentation_en.gif)
This unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source.
The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next five years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation.
The report is available by section, and can be customized to specific information needs and budget.
Coagulation testing in general, and Proteins C and S testing specifically, will become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the Proteins C and S testing closer to the patient, creating additional opportunities and challenges for suppliers.
This report presents a detailed analysis of the Proteins C and S testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5-year test volume forecasts by country and market segment.
The report examines market applications of chromogenic substrates, monoclonal antibodies, immunoassays, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.
Contains 194 pages and 15 tables
The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next five years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation.
The report is available by section, and can be customized to specific information needs and budget.
Coagulation testing in general, and Proteins C and S testing specifically, will become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the Proteins C and S testing closer to the patient, creating additional opportunities and challenges for suppliers.
This report presents a detailed analysis of the Proteins C and S testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5-year test volume forecasts by country and market segment.
The report examines market applications of chromogenic substrates, monoclonal antibodies, immunoassays, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.
Contains 194 pages and 15 tables
I. INTRODUCTION
II. MARKET AND TECHNOLOGY OVERVIEW
A. Introduction
B. Clinical Significance and Current Laboratory Procedures
C. Coagulation Instrumentation Review: Leading analyzers marketed by Abbott, Beckman Coulter/Danaher, Becton Dickinson, Diagnostica Stago, Grifols, Helena Laboratories, IL/Werfen, Roche, Sekisui Diagnostics, Siemens Healthineers, Sysmex, and Thermo Fisher.
D. Major in Vitro Diagnostic Technologies and Their
Potential Applications
E. Chromogenic Substrates
F. Monoclonal and Polyclonal Antibodies
G. Immunoassays
a. Applications
b. Technological Principle
c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Dot Immunobinding Assays
Capillary Immunoassays
Enzyme Amplification
Electrochemical Immunoassay
d. Fluorescent Immunoassays
Fluorescence Polarization
Time-Resolved Pulse Fluorescence
Fluorescence Lifetime
e. Latex Agglutination
f. Immunoprecipitation
H. Microcomputers
I. AUTOMATION
6. Robotics
7. DNA Probes
a. Overview
b. Amplification Methods
8. Artificial Intelligence
9. Dry Chemistry
10. Biosensors
III. FRANCE: TEST VOLUME FORECASTS BY MARKET SEGMENT
IV. GERMANY: TEST VOLUME FORECASTS BY MARKET SEGMENT
V. ITALY: TEST VOLUME FORECASTS BY MARKET SEGMENT
VI. JAPAN: TEST VOLUME FORECASTS BY MARKET SEGMENT
VII. SPAIN: TEST VOLUME FORECASTS BY MARKET SEGMENT
VIII. UK: TEST VOLUME FORECASTS BY MARKET SEGMENT
IX. USA: TEST VOLUME FORECASTS BY MARKET SEGMENT
X. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
XI. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Market
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types Of Distributors
7. Market Segmentation
XII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XIII. COMPETITIVE ASSESSMENTS
The report provides strategic assessments of over 20 leading coagulation market players and start-up companies with innovative technologies and products, including:
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Diagnostica Stago
Grifols
Helena Laboratories
IL/Werfen
Roche
Sekisui Diagnostics
Siemens Healthineers
Sysmex
Thermo Fisher, and others
II. MARKET AND TECHNOLOGY OVERVIEW
A. Introduction
B. Clinical Significance and Current Laboratory Procedures
C. Coagulation Instrumentation Review: Leading analyzers marketed by Abbott, Beckman Coulter/Danaher, Becton Dickinson, Diagnostica Stago, Grifols, Helena Laboratories, IL/Werfen, Roche, Sekisui Diagnostics, Siemens Healthineers, Sysmex, and Thermo Fisher.
D. Major in Vitro Diagnostic Technologies and Their
Potential Applications
E. Chromogenic Substrates
F. Monoclonal and Polyclonal Antibodies
G. Immunoassays
a. Applications
b. Technological Principle
c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Dot Immunobinding Assays
Capillary Immunoassays
Enzyme Amplification
Electrochemical Immunoassay
d. Fluorescent Immunoassays
Fluorescence Polarization
Time-Resolved Pulse Fluorescence
Fluorescence Lifetime
e. Latex Agglutination
f. Immunoprecipitation
H. Microcomputers
I. AUTOMATION
6. Robotics
7. DNA Probes
a. Overview
b. Amplification Methods
8. Artificial Intelligence
9. Dry Chemistry
10. Biosensors
III. FRANCE: TEST VOLUME FORECASTS BY MARKET SEGMENT
IV. GERMANY: TEST VOLUME FORECASTS BY MARKET SEGMENT
V. ITALY: TEST VOLUME FORECASTS BY MARKET SEGMENT
VI. JAPAN: TEST VOLUME FORECASTS BY MARKET SEGMENT
VII. SPAIN: TEST VOLUME FORECASTS BY MARKET SEGMENT
VIII. UK: TEST VOLUME FORECASTS BY MARKET SEGMENT
IX. USA: TEST VOLUME FORECASTS BY MARKET SEGMENT
X. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
XI. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Market
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types Of Distributors
7. Market Segmentation
XII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XIII. COMPETITIVE ASSESSMENTS
The report provides strategic assessments of over 20 leading coagulation market players and start-up companies with innovative technologies and products, including:
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Diagnostica Stago
Grifols
Helena Laboratories
IL/Werfen
Roche
Sekisui Diagnostics
Siemens Healthineers
Sysmex
Thermo Fisher, and others
LIST OF TABLES
Major Companies Developing or Marketing Tests
France
Test Volume Forecasts by Market Segment
Germany
Test Volume Forecasts by Market Segment
Italy
Test Volume Forecasts by Market Segment
Japan
Test Volume Forecasts by Market Segment
Spain
Test Volume Forecasts by Market Segment
U.K.
Test Volume Forecasts by Market Segment
U.S.A.
Test Volume Forecasts by Market Segment
Major Companies Developing or Marketing Tests
France
Test Volume Forecasts by Market Segment
Germany
Test Volume Forecasts by Market Segment
Italy
Test Volume Forecasts by Market Segment
Japan
Test Volume Forecasts by Market Segment
Spain
Test Volume Forecasts by Market Segment
U.K.
Test Volume Forecasts by Market Segment
U.S.A.
Test Volume Forecasts by Market Segment